| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Common Stock | Options Exercise | $117,018 | +10,638 | +3.5% | $11.00 | 314,816 | 08 Feb 2022 | Direct | F1 |
| transaction | AORT | Common Stock | Sale | $188,771 | -10,638 | -3.4% | $17.74 | 304,178 | 08 Feb 2022 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | StockOption(RightTo Buy) | Options Exercise | $117,018 | -10,638 | -33% | $11.00 | 21,277 | 08 Feb 2022 | Common Stock | 10,638 | $11.00 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 |
| F2 | Reflects weighted average price. Range of prices were between $17.4 to $17.89. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 |